IntraPace Overview
IntraPace, in stealth mode, is developing an endoscopically delivered gastric pacemaker for obesity treatment. The device is used in an outpatient procedure designed to take less than an hour and which requires no sedation or anatomic alterations according to the company.
Key People
Management
Board of Directors
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 08/16/2006 | Series D | 30M | Unknown |
Products
No product information added yet. Add product information.
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
No related companies were found.
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Web Metrics
View All Web Metrics »News & Blogs
View All News »- Latest
- Most Popular
- Submit a Story »
Personalized Data Input Portal and Online Patient Community to Be Launched at the World Congress of the International Federation for the Surgery of Obesity
Aug 30, 2011 - 0 comments
IntraPace Receives CE Mark Certification for Personal Wireless Connection With the abilitiĀ® System
Aug 10, 2011 - 0 comments
IntraPace on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...

